Pfizer Inc (PFE)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 213,396,000 | 219,476,000 | 216,193,000 | 221,095,000 | 226,501,000 | 215,021,000 | 220,168,000 | 195,617,000 | 197,206,000 | 195,349,000 | 195,290,000 | 183,841,000 | 181,477,000 | 179,188,000 | 169,920,000 | 158,818,000 | 154,229,000 | 178,983,000 | 177,934,000 | 166,336,000 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $213,396,000K
= 0.00
Pfizer Inc has consistently maintained a debt-to-assets ratio of 0.00 across multiple quarters spanning from March 31, 2020, to December 31, 2024. This indicates that the company has not relied heavily on debt to finance its operations and assets during this period. A lower debt-to-assets ratio generally signifies lower financial risk and a strong financial position, as it suggests that the company's assets are largely financed through equity rather than debt. Pfizer Inc's ability to sustain a debt-to-assets ratio of 0.00 over an extended period reflects prudent financial management and a solid balance sheet structure.
Peer comparison
Dec 31, 2024